These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3146500)

  • 41. Thyrotropin-releasing hormone release from rat pancreas is stimulated by serotonin but inhibited by carbachol.
    Lamberton P; Wu P; Jackson IM
    Endocrinology; 1985 Nov; 117(5):1834-8. PubMed ID: 3930219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on TRH-binding protein in rat serum].
    Mori M; Iriuchijima T; Murakami M; Kobayashi S
    Nihon Naibunpi Gakkai Zasshi; 1989 Mar; 65(3):174-81. PubMed ID: 2504624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The protective effect of 5-HT3 receptor antagonist in thyrotropin releasing hormone-induced gastric lesions.
    Erin N; Yegen BC; Oktay S
    Peptides; 1997; 18(6):893-8. PubMed ID: 9285940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative effects of eel calcitonin, salmon calcitonin and [Asu1,7]eel calcitonin on hypophyseal and osteoblastic function.
    Sortino MA; Aleppo G; Scapagnini U; Canonico PL
    Gynecol Endocrinol; 1993 Jun; 7(2):89-96. PubMed ID: 8213232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eel calcitonin induces creatine kinase BB activity in the rat kidney medulla.
    Bernardini R; Fiore CE; Insirello L; Pistritto M; Costa V; Clementi G
    Int J Tissue React; 1992; 14(1):25-9. PubMed ID: 1399319
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measurements of thyrotropin-releasing hormone-like material in human peripheral blood by affinity chromatography and radioimmunoassay.
    Mallik TK; Wilber JF; Pegues J
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1194-8. PubMed ID: 6122693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of restraint stress by systemic (Asu1,7) eel-calcitonin.
    Clementi G; Prato A; Rapisarda E; Conforto G; Mangano O; Caruso A; Scapagnini U
    J Endocrinol Invest; 1985 Dec; 8(6):543-6. PubMed ID: 3833898
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of gastric secretion and ulcer formation with synthetic salmon calcitonin in animal experiments.
    Doepfner W; Briner U
    Triangle; 1977; 16(2):105-13. PubMed ID: 929669
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of water-immersion-induced stress and intraperitoneal administration of brain-gut peptides upon immunoreactive thyrotropin-releasing hormone and prostaglandin E2 concentrations in the rat stomach.
    Maeda Y; Morise K; Kusugami K; Uchida K; Furusawa A; Kaneko H; Nakada K; Mitsuma T; Kurimoto F
    Gastroenterol Jpn; 1991 Aug; 26(4):417-23. PubMed ID: 1916149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of TRH and anti-TRH serum in experimental ulcerogenesis in the rat].
    Bagarani M; Genco A; Polito M; Verde B; Rabino R; Materia A; Munari C
    Minerva Chir; 1986 Jul; 41(13-14):1105-7. PubMed ID: 3093934
    [No Abstract]   [Full Text] [Related]  

  • 51. Thyrotropin-releasing hormone immunoreactivity in the gastrointestinal tract of man.
    Dolva LO; Hanssen KF; Aadland E; Sand T
    J Clin Endocrinol Metab; 1983 Mar; 56(3):524-9. PubMed ID: 6401759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analgesic activity of a synthetic analogue of eel-calcitonin and its effect on the spontaneous activity of brainstem neurons in the rat.
    Prato A; Scapagnini U; Rapisarda E; Giuffrida R; Palmeri A; Caruso A; Clementi G
    Neurosci Lett; 1987 Oct; 81(3):303-8. PubMed ID: 3431745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cold-restraint- and TRH-induced ulcer models demonstrate different biochemical and morphological manifestations in gastric and hepatic tissues in rats. Role of calcitonin.
    Erin N; Okar I; Oktay S; Ercan F; Arbak S; Yeğen BC
    Dig Dis Sci; 1996 Jan; 41(1):55-64. PubMed ID: 8565767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyrotropin-releasing hormone immunoreactivity in human blood, urine, spinal fluid, amniotic fluid, saliva, and gastric juice.
    Suhonen-Malm AS
    Acta Endocrinol (Copenh); 1987 Apr; 114(4):552-8. PubMed ID: 3107296
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High pressure liquid chromatography purification of human urinary samples for thyrotropin-releasing hormone radioimmunoassay.
    Leppäluoto J; Suhonen AS
    J Clin Endocrinol Metab; 1982 May; 54(5):914-8. PubMed ID: 6801077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyrotropin-releasing hormone cannot be detected in plasma from normal subjects.
    Iversen E
    J Clin Endocrinol Metab; 1986 Aug; 63(2):516-9. PubMed ID: 3088027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does salmon calcitonin influence the motility of the human gastrointestinal tract? An electromanometric and endoscopic study.
    Paul F
    Z Gastroenterol Verh; 1976; (10):23-7. PubMed ID: 64048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of intracerebroventricular administration of rat calcitonin gene-related peptide (CGRP), human calcitonin and [Asu1,7]-eel calcitonin on gastric acid secretion in rats.
    Okimura Y; Chihara K; Abe H; Kaji H; Kita T; Kashio Y; Fujita T
    Endocrinol Jpn; 1986 Apr; 33(2):273-7. PubMed ID: 3489610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concentrations of thyrotropin-releasing hormone in the brain of ataxic mice.
    Mitsuma T; Adachi K; Ando K
    J Neurol Sci; 1986 Sep; 75(2):135-9. PubMed ID: 3093641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intraventricular calcitonin inhibits gastric acid secretion.
    Morley JE; Levine AS; Silvis SE
    Science; 1981 Nov; 214(4521):671-3. PubMed ID: 7292006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.